Cutler Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,300
Closed -$149K 4310
2018
Q4
$142K Buy
3,300
+1,000
+43% +$49.9K 0.01% 824
2018
Q3
$130K Buy
+2,300
New +$121K 0.01% 1056
2017
Q4
Sell
-85
Closed -$2K 5240
2017
Q3
$2K Sell
85
-601
-88% -$18.4K ﹤0.01% 5067
2017
Q2
$22K Sell
686
-1,585
-70% -$49.8K ﹤0.01% 3317
2017
Q1
$67K Buy
2,271
+1,794
+376% +$49K ﹤0.01% 2103
2016
Q4
$11K Sell
477
-18,222
-97% -$414K ﹤0.01% 4085
2016
Q3
$422K Buy
18,699
+16,532
+763% +$389K 0.02% 696
2016
Q2
$51K Buy
+2,167
New +$52K ﹤0.01% 2327
2016
Q1
Sell
-5,100
Closed -$125K 6727
2015
Q4
$141K Buy
+5,100
New +$128K 0.01% 1468

Other funds holding GMED

Cutler Group's GMED Position: Q1 2019 in Review

Cutler Group sold out of Globus Medical (GMED) in Q1 2019, closing a stake of 3,300 shares — an estimated $149K sold.

Cutler Group first reported a position in GMED in Q4 2015 and held it in 9 quarters. The position peaked at $422K in Q3 2016. 269 funds tracked by Wall St. Rank hold GMED as of Q1 2019.

  • Cutler Group reported no remaining Globus Medical position as of Q1 2019 after selling out during the quarter.
  • Cutler Group sold 3,300 Globus Medical shares in Q1 2019, an estimated $149K.
  • Cutler Group first reported a position in Globus Medical in Q4 2015 and held it in 9 quarters.
  • Cutler Group's Globus Medical position peaked at $422K in Q3 2016.
  • 269 funds tracked by Wall St. Rank held Globus Medical as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.